| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 0 | 131.809 | 199.630 | 189.375 | 204.727 |
| Total Income - EUR | - | - | - | - | 0 | 809 | 146.113 | 199.634 | 190.035 | 204.739 |
| Total Expenses - EUR | - | - | - | - | 26 | 5.038 | 115.145 | 169.882 | 183.143 | 223.378 |
| Gross Profit/Loss - EUR | - | - | - | - | -26 | -4.229 | 30.969 | 29.751 | 6.892 | -18.639 |
| Net Profit/Loss - EUR | - | - | - | - | -26 | -4.229 | 29.536 | 27.755 | 4.991 | -23.046 |
| Employees | - | - | - | - | 0 | 1 | 1 | 2 | 3 | 3 |
Check the financial reports for the company - Leeafarma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 660 | 1.473 | 2.987 | 2.091 | 1.272 |
| Current Assets | - | - | - | - | 42 | 332 | 58.734 | 61.919 | 59.922 | 50.283 |
| Inventories | - | - | - | - | 0 | 0 | 20.399 | 23.888 | 23.839 | 23.977 |
| Receivables | - | - | - | - | 0 | 305 | 34.141 | 34.619 | 30.831 | 19.818 |
| Cash | - | - | - | - | 42 | 27 | 4.193 | 3.413 | 5.251 | 6.489 |
| Shareholders Funds | - | - | - | - | 16 | -4.213 | 25.416 | 53.250 | 57.311 | 33.880 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 26 | 9.508 | 39.043 | 14.891 | 8.397 | 17.675 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Leeafarma S.r.l.